HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elise E Drouin Selected Research

Peptides (Polypeptides)

1/2017Immunogenic HLA-DR-Presented Self-Peptides Identified Directly from Clinical Samples of Synovial Tissue, Synovial Fluid, or Peripheral Blood in Patients with Rheumatoid Arthritis or Lyme Arthritis.
3/2011Peptides presented by HLA-DR molecules in synovia of patients with rheumatoid arthritis or antibiotic-refractory Lyme arthritis.
4/2008Searching for borrelial T cell epitopes associated with antibiotic-refractory Lyme arthritis.
1/2008Human homologues of a Borrelia T cell epitope associated with antibiotic-refractory Lyme arthritis.
4/2006Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide.
11/2004Molecular characterization of the OspA(161-175) T cell epitope associated with treatment-resistant Lyme arthritis: differences among the three pathogenic species of Borrelia burgdorferi sensu lato.
2/2003Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elise E Drouin Research Topics

Disease

20Lyme Disease (Disease, Lyme)
01/2017 - 02/2003
14Arthritis (Polyarthritis)
01/2017 - 02/2003
10Infections
05/2016 - 11/2004
5Erythema
05/2016 - 05/2005
4Rheumatoid Arthritis
08/2017 - 03/2011
3Inflammation (Inflammations)
11/2013 - 07/2010
1Neoplasms (Cancer)
01/2018
1Fibrosis (Cirrhosis)
10/2015
1Autoimmune Diseases (Autoimmune Disease)
01/2013
1Disease Susceptibility (Diathesis)
04/2008
1Synovitis
11/2007
1Arthralgia (Joint Pain)
05/2005
1Facial Paralysis (Facial Palsy)
05/2005

Drug/Important Bio-Agent (IBA)

17Anti-Bacterial Agents (Antibiotics)IBA
05/2016 - 02/2003
9HLA-DR Antigens (HLA-DR)IBA
01/2017 - 02/2003
8EpitopesIBA
05/2016 - 02/2003
7Peptides (Polypeptides)IBA
01/2017 - 02/2003
6AutoantigensIBA
08/2017 - 03/2011
6OspA proteinIBA
02/2011 - 02/2003
5Proteins (Proteins, Gene)FDA Link
05/2016 - 05/2005
4AutoantibodiesIBA
05/2016 - 02/2014
4T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
12/2015 - 11/2004
3AntibodiesIBA
01/2018 - 08/2014
3CytokinesIBA
02/2014 - 06/2013
2AntigensIBA
01/2017 - 04/2006
2HLA Antigens (Human Leukocyte Antigens)IBA
01/2017 - 12/2015
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2014 - 01/2013
2Dichlororibofuranosylbenzimidazole (DRB)IBA
04/2006 - 02/2003
1Peptide TIBA
05/2016
1Apolipoprotein B-100 (Apo B 100)IBA
12/2015
1Annexin A2 (Annexin II)IBA
10/2015
1ChemokinesIBA
02/2014
1Interleukin-23 (Interleukin 23)IBA
02/2014
1KIR ReceptorsIBA
11/2013
1Immunoglobulins (Immunoglobulin)IBA
11/2013
1NK Cell Lectin-Like Receptor Subfamily KIBA
11/2013
1InterferonsIBA
06/2013
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2013
11-oleoyl-2-stearoylphosphatidylcholineIBA
06/2011
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
06/2011
1VaccinesIBA
02/2011
1N- (2- (4- (4- chlorophenyl)piperazin- 1- yl)ethyl)- 3- methoxybenzamide (PB 12)IBA
07/2010
1Antirheumatic Agents (DMARD)IBA
07/2010
1ProteomeIBA
04/2008
1Indicators and Reagents (Reagents)IBA
11/2007
1HLA-DRB1*04:01 antigenIBA
11/2007
1Glutathione Transferase (Glutathione S-Transferase)IBA
05/2005
1Membrane Proteins (Integral Membrane Proteins)IBA
05/2005
1Immunoglobulin G (IgG)IBA
05/2005
1Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA
02/2003

Therapy/Procedure

1Synovectomy
07/2010
1Therapeutics
11/2007